 |
市場調查報告書
商品編碼
2148320
心臟衰竭即時檢測和遠端檢測設備市場：按設備類型、檢測類型、生物標記、技術、應用、最終用戶和地區分類Heart Failure POC and LOC Devices Market, By Device Type, By Test Type, By Biomarker, By Technology, By Application, By End User, By Geography |
||||||
價格
簡介目錄
2026年，用於治療心臟衰竭的即時檢測（POC）和遠端檢測（LOC）設備的市場規模估計為1.857億美元，預計到2033年將達到4.984億美元。預計從2026年到2033年，其複合年成長率將達到15.1%。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年： | 2025 | 2026年市場規模： | 1.857億美元 |
| 歷史數據時期： | 2020年至2024年 | 預測期： | 2026年至2033年 |
| 2026年至2033年預測期間的複合年成長率： | 15.10% | 2033年市場規模預測： | 4.984億美元 |
心臟衰竭是一種慢性進行性心血管疾病，影響全球超過6,400萬人。在這種情況下，心臟無法泵出足夠的血液來滿足身體的氧氣和代謝需求。隨著疾病負擔的加重，人們越來越需要快速、準確的生物標記診斷方法，例如BNP、NT-proBNP和肌鈣蛋白。
即時檢測（POC）和晶片實驗室（LOC）設備可在急診室、診所和居家照護環境中實現快速、分散的心臟監測。微流體、生物感測器、奈米技術和數位健康領域的進步正使這些技術更加便攜、精準和高效，從而擴大其在現代心臟衰竭診斷和監測中的應用。
市場動態
全球心臟衰竭心臟衰竭(POC) 和線下檢測 (LOC) 設備市場成長的主要促進因素是心臟衰竭衰竭盛行率的不斷上升，以及人口老化和高血壓、糖尿病、肥胖症和冠狀動脈疾病盛行率的增加。此外，人們越來越傾向於分散式、以患者為中心的醫療服務模式，加上微流體、生物感測器、無線連接和人工智慧技術的進步，進一步提升了急診、門診和遠端醫療等場景下對快速、精準心臟診斷的需求。
然而，該市場面臨許多限制因素，包括高昂的研發和製造成本、嚴格的監管要求、準確性問題、醫療基礎設施有限以及保險報銷方面的挑戰。儘管如此，新興市場對居家心臟監測、物聯網連接診斷、雲端資料管理和預測分析日益成長的需求，以及醫療服務可近性的改善，將為全球心臟衰竭即時檢測（POC）和遠端檢測（LOC）設備市場創造新的成長機會。
本次調查的主要特點
- 本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
- 此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
- 本研究基於以下參數分析了全球心臟衰竭POC 和 LOC 設備市場的主要參與者：公司概況、產品系列、主要亮點、財務績效和策略。
- 本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、型號升級、市場擴張和行銷策略做出明智的決策。
- 這份「全球心臟衰竭即時檢測和遠端檢測設備市場」報告的目標受群眾外包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師等行業利益相關相關人員。
- 相關人員可以利用全球心臟衰竭POC 和 LOC 設備市場分析中使用的各種策略矩陣來促進決策。
目錄
第1章：研究目標與前提條件
- 分析目的
- 先決條件
- 簡稱
第2章 市場展望
- 報告說明
- 市場定義和範圍
- 執行摘要
第3章：市場動態、監管與趨勢分析
- 市場動態
- 影響分析
- 主要亮點
- 監管趨勢
- 設備類型發布和批准
- PEST分析
- 波特的分析
- 市場機遇
- 監管趨勢
- 產業趨勢
第4章 全球心臟衰竭即時檢測與分級診療設備市場：依設備類型分類，2021-2033年
- 即時診斷（POC）設備
- 晶片實驗室（LOC）設備
第5章 全球心臟衰竭即時檢測與局部檢測設備市場：依檢測類型分類，2021-2033年
- 蛋白質體學檢測
- 代謝體學學檢測
- 基因組檢測
第6章 全球心臟衰竭即時檢測與分級檢測設備市場：依生物標記分類，2021-2033年
- BNP／NT-proBNP
- 肌鈣蛋白
- 多生物標記檢測
- 其他
第7章 全球心臟衰竭即時檢測與分級診療設備市場：依技術分類，2021-2033年
- 微流體技術
- 陣列系統
- 基於免疫檢測的系統
- 其他
第8章 全球心臟衰竭即時檢測與分級診療設備市場：依應用領域分類，2021-2033年
- 急性心臟衰竭的診斷
- 慢性心臟衰竭的監測
- 風險分層及再入院預防
- 治療最佳化
- 其他
第9章 全球心臟衰竭即時檢測與分級診療設備市場：依最終用戶分類，2021-2033年
- 醫院
- 專科循環系統中心
- 基層醫療和急診中心
- 診斷檢查室
- 居家照護和遠端患者監護
- 其他
第10章 全球心臟衰竭即時檢測與分級診療設備市場：按地區分類，2021-2033年
- 北美洲
- 美國
- 加拿大
- 拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
- 歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
- 亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
- 中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
- 非洲
- 南非
- 北非
- 中非
第11章 競爭格局
- Abbott Laboratories
- Hoffmann-La Roche Ltd.
- Siemens Healthineers AG
- Danaher Corporation
- QuidelOrtho Corporation
- bioMerieux SA
- Becton, Dickinson and Company
- Trinity Biotech plc
- Jant Pharmacal Corporation
- Werfen, SA
第12章 分析師建議
- 機會分析
- 分析師意見
- Coherent Opportunity Map
第13章 參考文獻與調查方法
- 參考
- 調查方法
- 關於本公司
簡介目錄
Product Code: CMI10035
Heart Failure POC and LOC Devices Market is estimated to be valued at USD 185.7 Mn in 2026 and is expected to reach USD 498.4 Mn by 2033, growing at a compound annual growth rate (CAGR) of 15.1% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 185.7 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 15.10% | 2033 Value Projection: | USD 498.4 Mn |
Heart failure is a chronic, progressive disease of the cardiovascular system affecting more than 64 million people worldwide, where the heart fails to pump sufficient blood to meet the body's oxygen and metabolic needs. The increasing disease burden is driving the need for rapid and accurate diagnostic solutions for biomarkers such as BNP, NT-proBNP, troponin.
Point-of-Care (POC) and Lab-on-Chip (LOC) devices are enabling rapid and decentralized cardiac testing in emergency departments, clinics, and home-care settings. Progress in microfluidics, biosensors, nanotechnology, and digital health is making these technologies more portable, accurate, and efficient, thus facilitating their expanding contribution to modern heart-failure diagnosis and monitoring.
Market Dynamics
The global heart failure POC and LOC devices market is driven by increase in the prevalence of heart failure as well as increase in the aging population along with increase in the prevalence of hypertension, diabetes, obesity and coronary artery disease. The increase in the preference for decentralized patient-centric care and advances in microfluidics, biosensors, wireless connectivity and artificial intelligence is further increasing the demand for rapid and accurate cardiac diagnostics in emergency, outpatient and remote-care settings.
However, a number of constraints are present in the market, such as high development and manufacturing costs, strict regulatory requirements, accuracy concerns, limited healthcare infrastructure, and reimbursement challenges. Nevertheless, growing demand for home-based cardiac monitoring, IoT-connected diagnostics, cloud-based data management, and predictive analytics, coupled with improving healthcare access in emerging economies will offer new opportunities for growth in the global heart failure POC and LOC devices market.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global heart failure POC and LOC devices market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Abbott Laboratories, F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, Danaher Corporation, QuidelOrtho Corporation, bioMerieux S.A., Becton, Dickinson and Company, Trinity Biotech plc, Jant Pharmacal Corporation, and Werfen, S.A.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global heart failure POC and LOC devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global heart failure POC and LOC devices market
Market Segmentation
- Device Type Insights (Revenue, USD Mn, 2021 - 2033)
- Point-of-Care (POC) Devices
- Lab-on-Chip (LOC) Devices
- Test Type Insights (Revenue, USD Mn, 2021 - 2033)
- Proteomic Testing
- Metabolomic Testing
- Genomic Testing
- Biomarker Insights (Revenue, USD Mn, 2021 - 2033)
- BNP/NT-proBNP
- Troponin
- Multi-Biomarker Panels
- Others
- Technology Insights (Revenue, USD Mn, 2021 - 2033)
- Microfluidics
- Array-Based Systems
- Immunoassay-Based Systems
- Others
- Application Insights (Revenue, USD Mn, 2021 - 2033)
- Acute Heart Failure Diagnosis
- Chronic Heart Failure Monitoring
- Risk Stratification and Readmission Prevention
- Therapy Optimization
- Others
- End User Insights (Revenue, USD Mn, 2021 - 2033)
- Hospitals
- Specialty Cardiology Centers
- Primary Care and Urgent Care Centers
- Diagnostic Laboratories
- Homecare and Remote Patient Monitoring
- Others
- Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Abbott Laboratories
- Hoffmann-La Roche Ltd
- Siemens Healthineers AG
- Danaher Corporation
- QuidelOrtho Corporation
- bioMerieux S.A.
- Becton, Dickinson and Company
- Trinity Biotech plc
- Jant Pharmacal Corporation
- Werfen, S.A.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Heart Failure POC and LOC Devices Market, By Device Type
- Global Heart Failure POC and LOC Devices Market, By Test Type
- Global Heart Failure POC and LOC Devices Market, By Biomarker
- Global Heart Failure POC and LOC Devices Market, By Technology
- Global Heart Failure POC and LOC Devices Market, By Application
- Global Heart Failure POC and LOC Devices Market, By End User
- Global Heart Failure POC and LOC Devices Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Device Type Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Market Opportunities
- Regulatory Scenario
- Industry Trends
4. Global Heart Failure POC and LOC Devices Market, By Device Type, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Point-of-Care (POC) Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Lab-on-Chip (LOC) Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
5. Global Heart Failure POC and LOC Devices Market, By Test Type, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Proteomic Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Metabolomic Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Genomic Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
6. Global Heart Failure POC and LOC Devices Market, By Biomarker, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- BNP/NT-proBNP
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Troponin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Multi-Biomarker Panels
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
7. Global Heart Failure POC and LOC Devices Market, By Technology, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Microfluidics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Array-Based Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Immunoassay-Based Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
8. Global Heart Failure POC and LOC Devices Market, By Application, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Acute Heart Failure Diagnosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Chronic Heart Failure Monitoring
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Risk Stratification and Readmission Prevention
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Therapy Optimization
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
9. Global Heart Failure POC and LOC Devices Market, By End User, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Specialty Cardiology Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Primary Care and Urgent Care Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Homecare and Remote Patient Monitoring
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
10. Global Heart Failure POC and LOC Devices Market, By Region, 2021 - 2033, Value (USD Mn)
- Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Device Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Biomarker, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Device Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Biomarker, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Device Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Biomarker, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Device Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Biomarker, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Device Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Biomarker, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Device Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Biomarker, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
- South Africa
- North Africa
- Central Africa
11. Competitive Landscape
- Abbott Laboratories
- Company Highlights
- Device Type Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hoffmann-La Roche Ltd.
- Company Highlights
- Device Type Portfolio
- Key Developments
- Financial Performance
- Strategies
- Siemens Healthineers AG
- Company Highlights
- Device Type Portfolio
- Key Developments
- Financial Performance
- Strategies
- Danaher Corporation
- Company Highlights
- Device Type Portfolio
- Key Developments
- Financial Performance
- Strategies
- QuidelOrtho Corporation
- Company Highlights
- Device Type Portfolio
- Key Developments
- Financial Performance
- Strategies
- bioMerieux S.A.
- Company Highlights
- Device Type Portfolio
- Key Developments
- Financial Performance
- Strategies
- Becton, Dickinson and Company
- Company Highlights
- Device Type Portfolio
- Key Developments
- Financial Performance
- Strategies
- Trinity Biotech plc
- Company Highlights
- Device Type Portfolio
- Key Developments
- Financial Performance
- Strategies
- Jant Pharmacal Corporation
- Company Highlights
- Device Type Portfolio
- Key Developments
- Financial Performance
- Strategies
- Werfen, S.A.
- Company Highlights
- Device Type Portfolio
- Key Developments
- Financial Performance
- Strategies
12. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
13. References and Research Methodology
- References
- Research Methodology
- About us
